Literature DB >> 18325705

Clinical and histological findings in nephrogenic systemic fibrosis.

Shawn E Cowper1, Morgan Rabach, Michael Girardi.   

Abstract

Nephrogenic systemic fibrosis (NSF) is a relative newcomer to the world of medicine. NSF was introduced just over 10 years ago as nephrogenic fibrosing dermopathy, but with further investigation, its systemic nature was determined. The strict adherence to a definition requiring both clinical and pathological concordance has allowed for careful separation of this entity from other fibrosing disorders, leading eventually to the realization that gadolinium-based contrast agents were closely associated with its onset. As planned prospective studies get underway, it is of paramount importance that researchers and clinicians realize that NSF remains a very challenging diagnosis, and that both clinical and histopathological criteria must be employed to reach the most accurate diagnosis possible.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325705     DOI: 10.1016/j.ejrad.2008.01.016

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  25 in total

1.  Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

Authors:  Sameh K Morcos; John Haylor
Journal:  World J Radiol       Date:  2010-11-28

Review 2.  [Nephrogenic systemic fibrosis].

Authors:  Stefan Becker; Oliver Witzke; Andreas Kribben
Journal:  Med Klin (Munich)       Date:  2009-04-01

3.  CT and MR imaging of progressive dural involvement by nephrogenic systemic fibrosis.

Authors:  S Zelasko; M Hollingshead; M Castillo; T W Bouldin
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-14       Impact factor: 3.825

4.  Evaluation of a handheld creatinine measurement device for real-time determination of serum creatinine in radiology departments.

Authors:  Stefan Haneder; Alexandra Gutfleisch; Claudia Meier; Joachim Brade; Dieter Hannak; Stefan O Schoenberg; Christoph R Becker; Henrik J Michaely
Journal:  World J Radiol       Date:  2012-07-28

5.  Fibroblast response to lanthanoid metal ion stimulation: potential contribution to fibrotic tissue injury.

Authors:  William Jenkins; Patricia Perone; Kyle Walker; Narasimharao Bhagavathula; Muhammad Nadeem Aslam; Marissa DaSilva; Michael K Dame; James Varani
Journal:  Biol Trace Elem Res       Date:  2011-04-12       Impact factor: 3.738

Review 6.  Renal imaging in patients with renal impairment.

Authors:  Jason A Poff; Elizabeth M Hecht; Parvati Ramchandani
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

7.  Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review.

Authors:  Joseph Lunyera; Dinushika Mohottige; Anastasia-Stefania Alexopoulos; Hilary Campbell; C Blake Cameron; Nicole Sagalla; Timothy J Amrhein; Matthew J Crowley; Jessica R Dietch; Adelaide M Gordon; Andrzej S Kosinski; Sarah Cantrell; John W Williams; Jennifer M Gierisch; Belinda Ear; Karen M Goldstein
Journal:  Ann Intern Med       Date:  2020-06-23       Impact factor: 25.391

8.  Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.

Authors:  N Fretellier; Jm Idée; P Bruneval; S Guerret; F Daubiné; G Jestin; C Factor; N Poveda; A Dencausse; F Massicot; O Laprévote; C Mandet; N Bouzian; M Port; C Corot
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

9.  Gadolinium exposure disrupts iron homeostasis in cultured cells.

Authors:  Andrew J Ghio; Joleen M Soukup; Lisa A Dailey; Judy Richards; Zhongping Deng; Jerrold L Abraham
Journal:  J Biol Inorg Chem       Date:  2011-01-26       Impact factor: 3.358

10.  Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells.

Authors:  Li-Juan Fu; Jin-Xia Li; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2008-10-25       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.